You've worked in surgery long enough to form a valid opinion when you saw Surgibot. Plus it was soundly rejected by FDA and wasn't designed to meet the (then) new human factors criteria. That would have required a TOTAL redesign to ever be considered for use in this country. It went for cheap money for overseas use because it had no value in this country. Do you really think that Titan's designs are not worth more than Surgibot?
Unfortunately I don't fully believe an acquisition is imminent, but if it happened this year, it would be understandable given that some pieces seem to be lining up that way. My own assessment is that there may be a 25 to 33% chance of acquisition this year; otherwise I assume this misery will continue indefinitely. Even with funding, my guess is that my breakeven point would still be two years away. But as stupid as many of you seem to think they are, I can't believe they would let this go for the kind of money being talked about here.
Message in reply to:
SPORT19 Wednesday, 02/05/20 03:27:22 PM
Re: 66Mustang post# 103294 0
Post # 103307 of 103310
Lets say I agree with you on the value of SPORT. Why do you think the market cap is $17 million? FDA rejected Surgibot went for $29 million. It’s not like Titan isn’t known...it is. Mac has done plenty of investor conferences and it definitely has gotten word of mouth in the surgical community.
To be honest I’ve thought of buying at these levels with a sale looking more and more likely....but being burned at every step here has made me pause...
